fidarestat has been researched along with epiglucan in 1 studies
Studies (fidarestat) | Trials (fidarestat) | Recent Studies (post-2010) (fidarestat) | Studies (epiglucan) | Trials (epiglucan) | Recent Studies (post-2010) (epiglucan) |
---|---|---|---|---|---|
97 | 3 | 33 | 5,066 | 241 | 3,169 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdelsattar, AM; Al-Shenawy, HA; Ali, DA; Barhoma, RA; El-Deeb, OS; El-Sharaby, RM; Elesawy, RO; Eltokhy, AK; Eshra, KA; Ghanem, HB; Ibrahim, RR; Mashal, SS; Rizk, FH; Shalaby, RH | 1 |
1 other study(ies) available for fidarestat and epiglucan
Article | Year |
---|---|
Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat.
Topics: Adenosine Triphosphate; Aldehyde Reductase; Animals; beta-Glucans; Colitis, Ulcerative; DNA; Fatty Acids, Volatile; Gastrointestinal Microbiome; Mitochondria; NF-E2-Related Factor 2; Oxazolone; Rats; Rats, Wistar; Reactive Oxygen Species | 2023 |